SAN MATEO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated…
Topline results for the Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416)…
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed."This is the height of hypocrisy," said Duane Boise, CEO…
Research Grid (R.grid) launches new Site Feasibility solution to accelerate trial startups and expand global patient accessThe tool uses real-world…
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 /…
LITTLETON, COLORADO / ACCESS Newswire / August 6, 2025 / Colorado Eye Consultants is proud to announce that founding owner…
Expansion brings together top clinical leaders to help scale Eko's disease detection platform following major FDA clearances, reimbursement wins, and…
Second 2025 Release Unveils a First-of-Its-Kind Site-Facing Milestone Tracker to Streamline Site Activation, Drive Transparency, and Strengthen Site Alignment with Sponsors…
MyBladderCancerTeam and MyEndometrialCancer Team connect oncology patients with medically reviewed online content and support SAN FRANCISCO, Aug. 6, 2025 /PRNewswire/…
Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring…